The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2022 | What to look forward to at ELCC 2022
Triparna Sen, PhD, MS, BS, Memorial Sloan Kettering Cancer Center, New York, NY, talks on what she’s looking forward to at the European Lung Cancer Congress 2022, including talks on therapeutic resistance and novel therapeutic strategies in lung cancer. However, given Dr Sen interests, she is most excited for discussions on immunotherapeutic approaches for lung cancer treatment. This interview took place during the virtual European Lung Cancer Congress 2022.
